Loading...
Docoh

12 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2022 Q2
IKNA Ikena Oncology Inc
11 Aug 22
Quarterly report
6:03am
; integrating the culture of the target company with ours; preserving important strategic relationships and collaborations; and consolidating … are unable to successfully integrate them with our existing operations and company culture. We may encounter numerous difficulties in developing
10-Q
2022 Q1
IKNA Ikena Oncology Inc
12 May 22
Quarterly report
6:02am
employee morale and retaining key employees; integrating the culture of the target company with ours; preserving important strategic relationships … the benefit of acquiring such businesses if we are unable to successfully integrate them with our existing operations and company culture. We may
DEF 14A
IKNA Ikena Oncology Inc
27 Apr 22
Definitive proxy
4:32pm
positively to the collaborative culture among board members, and their knowledge of our business and understanding of the competitive landscape in which
10-K
2021 FY
IKNA Ikena Oncology Inc
17 Mar 22
Annual report
6:31am
in preclinical studies. In a three dimensional cell culture system, we observed that combined ERK5 and MEK inhibition led to synergistic antitumor activity … ), but not in the wildtype KRAS lung cancer cell line NCI-H520. Synergy of ERK5 and MEK inhibition in KRAS mutant but not wild type cells in 3D cell culture system
10-Q
2021 Q3
IKNA Ikena Oncology Inc
10 Nov 21
Quarterly report
6:05am
candidates or capabilities with ours; maintaining employee morale and retaining key employees; integrating the culture of the target company … with our existing operations and company culture. We may encounter numerous difficulties in developing, manufacturing and marketing any new products
10-Q
vn37jm7g
12 Aug 21
Quarterly report
4:21pm
10-Q
utrx2r9uywgqnt
13 May 21
Quarterly report
4:15pm
424B4
35hn3v1apju w7f3t
26 Mar 21
Prospectus supplement with pricing info
5:04pm
S-1/A
2f3ir780odzed
22 Mar 21
IPO registration (amended)
8:51am
S-1
5trilx16hu
5 Mar 21
IPO registration
2:59pm
DRS/A
mbweelf ne77295bb4v
10 Feb 21
Draft registration statement (amended)
7:00pm
DRS
ckgpyz oy5n
7 Jan 21
Draft registration statement
7:00pm
  • 1